Deciphera Pharmaceuticals Correlations

Summary

DCPHDelisted Stock

USD 13.32 0.36 2.63%

The current 90-days correlation between Deciphera Pharmaceuticals and Eagle Pharmaceuticals is 0.01 (i.e., Significant diversification). The correlation of Deciphera Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Deciphera Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Deciphera Pharmaceuticals LLC and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Deciphera Pharmaceuticals LLC and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Moving against Deciphera Stock

0.42	T	ATT Inc Aggressive Push	Pair Corr
0.42	WMT	Walmart Aggressive Push	Pair Corr
0.41	AXP	American Express Fiscal Year End 24th of January 2025	Pair Corr
0.36	HD	Home Depot Sell-off Trend	Pair Corr

Related Correlations Analysis

	EGRX	ANIP	PAHC	PBH	EVO	SUPN	COLL	NBIX	IRWD	ALKS
EGRX		0.37	-0.61	-0.4	-0.52	-0.4	0.51	0.04	0.52	-0.31	EGRX
ANIP	0.37		-0.14	0.03	-0.2	0.22	0.27	0.44	0.61	0.34	ANIP
PAHC	-0.61	-0.14		0.48	0.48	0.48	-0.58	-0.01	-0.37	0.27	PAHC
PBH	-0.4	0.03	0.48		0.88	0.78	-0.87	0.52	-0.25	0.39	PBH
EVO	-0.52	-0.2	0.48	0.88		0.66	-0.88	0.38	-0.35	0.24	EVO
SUPN	-0.4	0.22	0.48	0.78	0.66		-0.72	0.55	0.04	0.41	SUPN
COLL	0.51	0.27	-0.58	-0.87	-0.88	-0.72		-0.34	0.42	-0.1	COLL
NBIX	0.04	0.44	-0.01	0.52	0.38	0.55	-0.34		0.28	0.3	NBIX
IRWD	0.52	0.61	-0.37	-0.25	-0.35	0.04	0.42	0.28		0.16	IRWD
ALKS	-0.31	0.34	0.27	0.39	0.24	0.41	-0.1	0.3	0.16		ALKS
	EGRX	ANIP	PAHC	PBH	EVO	SUPN	COLL	NBIX	IRWD	ALKS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

EVO	+ 0.88	PBH
SUPN	+ 0.78	PBH
SUPN	+ 0.66	EVO
IRWD	+ 0.61	ANIP
NBIX	+ 0.55	SUPN
IRWD	+ 0.52	EGRX

High negative correlations

COLL	- 0.88	EVO
COLL	- 0.87	PBH
COLL	- 0.72	SUPN
PAHC	- 0.61	EGRX
COLL	- 0.58	PAHC
EVO	- 0.52	EGRX

Risk-Adjusted Indicators

There is a big difference between Deciphera Stock performing well and Deciphera Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Deciphera Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EGRX	3.94	(1.19)	0.00	26.43	0.00	0.00	9.24	(8.24)	53.71
ANIP	1.90	(0.22)	0.00	(0.06)	0.00	0.00	3.70	(3.75)	10.82
PAHC	1.82	0.18	0.04	1.10	1.72	(2.08)	3.86	(2.45)	9.05
PBH	0.95	0.14	0.09	0.32	1.03	(1.03)	1.90	(1.76)	5.58
EVO	4.09	0.60	0.07	(0.69)	5.42	(4.38)	9.82	(8.49)	33.99
SUPN	1.36	(0.03)	(0.01)	0.09	2.01	(1.35)	2.77	(2.71)	12.87
COLL	1.88	(0.43)	0.00	(0.25)	0.00	0.00	3.23	(4.47)	12.29
NBIX	1.53	(0.41)	0.00	(0.18)	0.00	0.00	3.10	(2.10)	18.87
IRWD	3.41	(0.63)	0.00	(0.15)	0.00	0.00	6.62	(7.54)	20.41
ALKS	1.75	(0.12)	(0.02)	0.04	2.08	(1.88)	4.14	(3.59)	9.74

Deciphera Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deciphera Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Deciphera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Deciphera Pharmaceuticals by comparing valuation metrics with similar companies.

Eagle Pharmaceuticals ANI Pharmaceuticals Phibro Animal Health Prestige Brand Holdings Evotec SE ADR Supernus Pharmaceuticals Collegium Pharmaceutical Neurocrine Biosciences Ironwood Pharmaceuticals Alkermes Plc Avadel Pharmaceuticals PLC Amphastar P Procaps Group SA Silver Spike Investment American Airlines Group

Risk & Return

Correlation

Deciphera Pharmaceuticals Corporate Management

Stephen Ruddy	VP Officer	Profile
Daniel Martin	Chief Commercial Officer	Profile
Margarida Duarte	Senior International	Profile
Kevin Brodbeck	Senior Officer	Profile
Lisa Price	Senior Officer	Profile
Matthew MD	Executive Officer	Profile

Still Interested in Deciphera Pharmaceuticals LLC?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC